Diabetes researchers have called for a rethink on type 1 diabetes, arguing for it to be redefined as an asymptomatic autoimmune disease that eventually leads to beta-cell destruction.

Moving away from viewing it as a metabolic disorder at the end stage of disease is a key step in prevention, they write in the Medical Journal of Australia.